Christin GALETZKA,Chris RUNDFELDT,Roland RUPP,Peder M. ANDERSEN
申请号：
US15723749
公开号：
US20180021289A1
申请日:
2017.10.03
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to pharmaceutical compositions containing dimethyl fumarate (DMF). More specifically, the present invention relates to a pharmaceutical composition for oral use in treating psoriasis by administering a low daily dosage in the range of 375 mg±5% dimethyl fumarate, wherein the pharmaceutical formulation is in the form of an erosion matrix tablet.
